Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases

被引：0
|
作者：
Min Shi
Zhongyin Yang
Sheng Lu
Wentao Liu
Zhentian Ni
Xuexin Yao
Zichen Hua
Runhua Feng
Yanan Zheng
Zhenqiang Wang
Birendra Kumar Sah
Mingmin Chen
Zhenglun Zhu
Changyu He
Chen Li
Jun Zhang
Chao Yan
Min Yan
Zhenggang Zhu
机构：
[1] Ruijin Hospital,Department of Oncology
[2] Shanghai Jiao Tong University School of Medicine,Department of General Surgery
[3] Shanghai Key Laboratory of Gastric Neoplasms,State Key Laboratory of Oncogenes and Related Genes
[4] Shanghai Institute of Digestive Surgery,undefined
[5] Ruijin Hospital,undefined
[6] Shanghai Jiao Tong University School of Medicine,undefined
[7] Shanghai Jiao Tong University School of Medicine,undefined
来源：
BMC Cancer | / 21卷
关键词：
Gastric cancer; Peritoneal metastasis; Oxaliplatin; S-1; Intraperitoneal paclitaxel;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Conversion surgery after S-1 plus oxaliplatin combination chemotherapy for advanced gastric cancer with multiple liver metastases
    Namikawa T.
    Tsuda S.
    Fujisawa K.
    Iwabu J.
    Uemura S.
    Tsujii S.
    Maeda H.
    Kitagawa H.
    Kobayashi M.
    Hanazaki K.
    Clinical Journal of Gastroenterology, 2018, 11 (4) : 297 - 301
  • [42] Gastrectomy in combination with S-1, intravenous, and intraperitoneal paclitaxel: A novel multidisciplinary treatment strategy for gastric cancer with peritoneal metastasis
    Ishigami, H.
    Kitayama, J.
    Kaisaki, S.
    Kato, M.
    Yamaguchi, H.
    Otani, K.
    Kamei, T.
    Nagawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis
    Yamaguchi, Hironori
    Kitayama, Joji
    Ishigami, Hironori
    Emoto, Shigenobu
    Yamashita, Hiroharu
    Watanabe, Toshiaki
    CANCER, 2013, 119 (18) : 3354 - 3358
  • [44] Phase II study of intraperitoneal paclitaxel plus S-1/paclitaxel for gastric cancer with positive peritoneal cytology: CY-PHOENIX trial.
    Aizawa, Masaki
    Ishigami, Hironori
    Yabusaki, Hiroshi
    Nashimoto, Atsushi
    Imamoto, Haruhiko
    Imano, Motohiro
    Yamashita, Hiroharu
    Kishi, Kentaro
    Kodera, Yasuhiro
    Uenosono, Yoshikazu
    Fujiwara, Yoshiyuki
    Hidemura, Akio
    Tamura, Shigeyuki
    Fukushima, Ryoji
    Yamaguchi, Hironori
    Kitayama, Joji
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [45] Gastrectomy after intravenous and intraperitoneal paclitaxel combined with oral S-1 for gastric cancer with peritoneal metastasis
    Kitayama, Joji
    Ishigami, Hironori
    Yamaguchi, Hironori
    Emoto, Shigenobu
    Watanabe, Toshiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [46] Clinical Study of S-1 Plus Oxaliplatin Versus S-1 Plus Cisplatin as First-Line Treatment for Elderly Patients with Advanced Gastric Cancer
    Bo Deng-feng
    Hu Xiu-fu
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2015, 3 (04): : 238 - 242
  • [47] Randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin for first-line treatment of advanced gastric cancer
    Higuchi, Katsuhiko
    Koizumi, Wasaburo
    Yamada, Yasuhide
    Nishikawa, Kazuhiro
    Gotoh, Masahiro
    Fuse, Nozomu
    Sugimoto, Naotoshi
    Nishina, Tomohiro
    Amagai, Kenji
    Chin, Keisho
    Niwa, Yasumasa
    Negoro, Yuji
    Imamura, Hiroshi
    Tsuda, Masahiro
    Yasui, Hirotumi
    Fujii, Hirofumi
    Yamaguchi, Kensei
    Yasui, Hisateru
    Hamada, Chikuma
    Hyodo, Ichinosuke
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [48] Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
    Dai, Yu-Hong
    Yu, Xiong-Jie
    Xu, Hui-Ting
    Zhuang, Liang
    Zhang, Ming-Sheng
    Zou, Yan-Mei
    Fu, Qiang
    Qiu, Hong
    Yuan, Xiang-Lin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [49] Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial
    Ishigami, Hironori
    Fujiwara, Yoshiyuki
    Fukushima, Ryoji
    Nashimoto, Atsushi
    Yabusaki, Hiroshi
    Imano, Motohiro
    Imamoto, Haruhiko
    Kodera, Yasuhiro
    Uenosono, Yoshikazu
    Amagai, Kenji
    Kadowaki, Shigenori
    Miwa, Hiroto
    Yamaguchi, Hironori
    Yamaguchi, Takuhiro
    Miyaji, Tempei
    Kitayama, Joji
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) : 1922 - +
  • [50] Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with oral S-1 for advanced gastric cancer with macroscopic peritoneal metastasis
    Yamaguchi, Hironori
    Ishigami, Hironori
    Emoto, Shigenobu
    Yamashita, Hiroharu
    Kitayama, Joji
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345